In this provacative opinion piece, Robert Goldberg, vice president of the Center for Medicine in the Public Interest, argues that Medicare and CMS cutbacks in reimbursements for crucial cancer fighting drugs could lead to a serious loss of lives. "Fewer drugs. Fewer seniors," he writes. "Maybe that should be Medicare's slogan for the future."
Trending:
Commentary: Fewer drugs, fewer seniors